Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Diabetes news

Show

From To
Cardiovascular disease in people with HIV

This issue of Research Initiative, Treatment Action (RITA!) carefully examines evidence from well over 100 studies on cardiovascular risk factors and the impact of individual and combined antiretrovirals on the heart.This RITA! also features an interview with the University of Wisconsin’s James Stein, perhaps the leading authority on cardiovascular disease in people with HIV. Stein offers frank and insightful answers to questions on cardiovascular risk, screening adults and children, the Framingham score, lipid targets, aspirin prophylaxis, and smoking.

Published
20 June 2013
From
RITA! / Center for AIDS Information and Advocacy
Less South Africans Dying of HIV/Aids, but More of Diabetes

Government's annual death report has confirmed the trend that less South Africans have been dying of HIV/AIDS-related diseases. However, more people are dying of non-communicable diseases such as diabetes. ...

Published
11 April 2013
From
AllAfrica.com
Protein Structure Discovery Could Lead to Better Treatments for HIV, Early Aging

Researchers at the University of Virginia School of Medicine have determined the molecular structure of a protein whose mutations have been linked to several early aging diseases, and to side effects of common HIV and AIDS medications.

Published
11 April 2013
From
University of Virginia press release
Every year of statin therapy boosts diabetes risk 10% in US HIV cohort

Every year of treatment with lipid-lowering statins boosted the risk of diabetes 10% in members of the HIV Outpatient Study (HOPS). The results confirm an earlier finding of self-reported diabetes associated with statin use in a large general-population study of US postmenopausal women, but the impact of statins seemed more modest in the HOPS analysis.

Published
07 March 2013
From
EATG / NATAP
Aggressive therapy for MDR-TB reduces risk of disease recurrence

Aggressive treatment of multidrug-resistant tuberculosis (MDR-TB) significantly reduces the risk of disease recurrence, investigators report in the online edition of Clinical Infectious Diseases. Patients who received

Published
31 December 2012
By
Michael Carter
Smoking the biggest single risk factor for acute heart disease in people with HIV

Smoking is the single biggest risk factor for acute coronary syndrome in HIV-positive adults, Spanish researchers report in the online edition of HIV Medicine. Smoking was a

Published
19 November 2012
By
Michael Carter
D:A:D model is good predictor of diabetes in HIV-positive people

A model developed by the Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study group proved a good predictor of diabetes in HIV-positive people, better than the Framingham model in certain circumstances.

Published
09 November 2012
From
International AIDS Society
Obesity is a risk factor for co-occuring chronic health problems in patients with HIV

Obesity is associated with the clustering of multiple health problems in HIV-positive people, investigators from the US report in the online edition of the Journal of Acquired Immune

Published
10 October 2012
By
Michael Carter
People with HIV have a poorer response to diabetes therapy

HIV infection is associated with a poorer response to therapy for diabetes, according to US research published in the online edition of AIDS. People taking antiretroviral therapy based

Published
12 September 2012
By
Michael Carter
Glucose metabolism worsens in HIV treatment-experienced taking NRTI-sparing regimens

Italian investigators have found evidence of worsening glucose tolerance in highly treatment-experienced HIV-positive patients treated with nucleoside-sparing regimens. The small study, which is published in the online edition

Published
24 August 2012
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.